Visceral leishmaniasis and HIV co-infection: WHO issues new guidelines with region-specific treatment recommendations
The World Health Organization (WHO) has published new guidelines for the treatment of visceral leishmaniasis in patients co-infected with the human immunodeficiency virus (HIV). The directive focuses on visceral leishmaniasis in East Africa and Southeast Asia. Visceral leishmaniasis or kala azar is caused by various Leishmania species in different geographical areas.1 In East Africa (Ethiopia, …